Ke et al., through robust statistical analysis of a large cohort, established a prognostic model termed the CI model, which integrates baseline serum IL-6 levels (sIL6) with NPC TNM staging (74). This evidence concerns the gene IL6 and nasopharyngeal carcinoma.